Jubilant Pharmova Limited — Updates, 10-10-2025: General Updates
10-10-2025 | 08:00 am
10-10-2025 | 08:00 am
Jubilant Pharmova's US unit, JHS, launched a new sterile injectables line (c. ₹1096 Cr investment) in Spokane. This adds 50% capacity, generating revenue, and targets doubling total capacity with a 4th line. Strong demand traction seen.
No comments yet. Be the first to comment!
